During the past decade, CSC Research -- Grove City Sleep Diagnostic Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "CSC Research -- Grove City Sleep Diagnostic Center" are "Narcolepsy" (2 trials). Many other conditions were trialed in "CSC Research -- Grove City Sleep Diagnostic Center" in a lesser frequency.

Most popular intervention types in "CSC Research -- Grove City Sleep Diagnostic Center" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Modafinil (Placebo)" (1 trials), "Modafinil at established dose" (1 trials), "Xyrem" (1 trials), "Xyrem Placebo" (1 trials) and "sodium oxybate" (1 trials). Other intervention names were less common.

The vast majority of trials in "CSC Research -- Grove City Sleep Diagnostic Center" are 2 trials for "All" genders.

Currently, there are NaN active trials in "CSC Research -- Grove City Sleep Diagnostic Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in CSC Research -- Grove City Sleep Diagnostic Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in CSC Research -- Grove City Sleep Diagnostic Center, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".